• Prehľad
  • Prevalencia obezity
  • Vodiči
  • Komorbidity
  • Zásady (k dispozícii iba v angličtine)
  • Contextual factors
Načítavam údaje, prosím, čakajte ...

Prevalencia obezity

Deti, 2013-2014

Typ prieskumu:Nameraná hodnota
Vek:4-19
Veľkosť vzorky:30579
Dotknutá oblasť:Národný
Odkazy:Paulino YC, Guerrero RT, Uncangco AA, Rosadino MG, Quinene JC, Natividad ZN. Overweight and Obesity Prevalence among Public School Children in Guam. J Health Care Poor Underserved. 2015;26(2 Suppl):53-62. doi:10.1353/hpu.2015.0066
Cutoffs:CDC

Estimated per capita fruit intake

Dospelí, 2017

Typ prieskumu:Nameraná hodnota
Vek:25+
Odkazy:Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
Definície (k dispozícii iba v angličtine):Estimated per-capita fruit intake (g/day)

Odhadovaný príjem spracovaného mäsa na obyvateľa

Dospelí, 2017

Typ prieskumu:Nameraná hodnota
Vek:25+
Odkazy:Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
Definície (k dispozícii iba v angličtine):Estimated per-capita processed meat intake (g per day)

Estimated per capita whole grains intake

Dospelí, 2017

Typ prieskumu:Nameraná hodnota
Vek:25+
Odkazy:Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
Definície (k dispozícii iba v angličtine):Estimated per-capita whole grains intake (g/day)

Duševné zdravie - poruchy depresie

Dospelí, 2021

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definície (k dispozícii iba v angličtine):Number living with depression per 100,000 population (adults 20+ years)

Muži, 2021

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definície (k dispozícii iba v angličtine):Number living with depression per 100,000 population (adults 20+ years)

Ženy, 2021

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definície (k dispozícii iba v angličtine):Number living with depression per 100,000 population (adults 20+ years)

Deti, 2021

Dotknutá oblasť:Národný
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definície (k dispozícii iba v angličtine):Number living with depressive disorder per 100,000 population (Under 20 years of age)

Chlapci, 2021

Dotknutá oblasť:Národný
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definície (k dispozícii iba v angličtine):Number living with depressive disorder per 100,000 population (Under 20 years of age)

Dievčatá, 2021

Dotknutá oblasť:Národný
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
Definície (k dispozícii iba v angličtine):Number living with depressive disorder per 100,000 population (Under 20 years of age)

Duševné zdravie - úzkostné poruchy

Dospelí, 2021

Vek:20+
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
Definície (k dispozícii iba v angličtine):Number living with anxiety per 100,000 population

Muži, 2021

Vek:20+
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
Definície (k dispozícii iba v angličtine):Number living with anxiety per 100,000 population

Ženy, 2021

Vek:20+
Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
Definície (k dispozícii iba v angličtine):Number living with anxiety per 100,000 population

Deti, 2021

Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Chlapci, 2021

Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Dievčatá, 2021

Odkazy:Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Rakovina pažeráka

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Indicence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Indicence per 100,000

Muži, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Ženy, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Rakovina prsníka

Ženy, 2022

Vek:20
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Rakovina hrubého čreva a konečníka

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Muži, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Ženy, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Rakovina pankreasu

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Muži, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Ženy, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Rakovina žlčníka

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Indicence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Indicence per 100,000

Muži, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Ženy, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Rakovina obličiek

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Muži, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Ženy, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Rakovina maternice

Ženy, 2022

Vek:20+
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Ženy, 2020

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today, accessed 10.01.2161
Definície (k dispozícii iba v angličtine):Age-standardized indicence rates per 100 000

Prevalencia cukrovky

Dospelí, 2024

Odkazy:Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org

Dospelí, 2021

Vek:20-79
Dotknutá oblasť:Národný
Odkazy:Reproduced with kind permission International Diabetes Federation.  IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org
Definície (k dispozícii iba v angličtine):Age-adjusted comparative prevalence of diabetes, %

Dospelí, 2019

Vek:20-79
Odkazy:Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org
Definície (k dispozícii iba v angličtine):Diabetes age-adjusted comparative prevalence (%).

Dospelí, 2017

Odkazy:Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org
Definície (k dispozícii iba v angličtine):Diabetes age-adjusted comparative prevalence (%).

Ovarian Cancer

Ženy, 2022

Vek:20+
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Leukemia

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Leukemia

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Liver and intrahepatic bile duct Cancer

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Multiple Myeloma

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Indicence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Indicence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Non Hodgkin Lymphoma

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000
Ak nie je uvedené inak, za nadváhu sa považuje, ak je BMI index medzi 25 kg a 29,9 kg/m² a za obezitu sa považuje, ak je BMI index vyšší ako 30 kg/m².

Thyroid Cancer

Muži, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Ženy, 2022

Vek:20+
Dotknutá oblasť:Národný
Odkazy:Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
Definície (k dispozícii iba v angličtine):Incidence per 100,000

Policies, Interventions and Actions

Guam Non-communicable disease strategic plan 2014-2018

Includes nutrition and obesity strategy and the goal of reducing obesity by 5% between 2014 and 2018.

Categories:Evidence of NCD strategy
Year(s):2014-2018
Target age group:Dospelí a deti
Organisation:Guam Department of Public Health and Social Services
Linked document:Download linked document

GNPR 2016-17 (q7) Breastfeeeding promotion and/or counselling

WHO Global Nutrition Policy Review 2016-2017 reported the evidence of breastfeeding promotion and/or counselling (q7)

Categories:Evidence of Breastfeeding promotion or related activity
Target age group:Dospelí
Organisation:Ministry of Health (information provided by the GINA progam)
Find out more:extranet.who.int
References:Information provided with kind permission of WHO Global database on the Implementation of Nutrition Action (GINA): https://extranet.who.int/nutrition/gina/en Please note the GINA website has been replaced by the GIFNA database and the GINA link will no longer work. You will find this document by searching this new database: https://gifna.who.int/

No actions could be found for the above criteria.

Contextual factors

Disclaimer: These contextual factors should be interpreted with care. Results are updated as regularly as possible and use very specific criteria. The criteria used and full definitions are available for download at the bottom of this page.

Tap on a tick to find out more about policies influencing this factor.

Labelling

Is there mandatory nutrition labelling?Absent
Front-of-package labelling?Absent
Back-of-pack nutrition declaration?Absent
Color coding?Absent
Warning label?Absent

Regulation and marketing

Are there fiscal policies on unhealthy products?Absent
Tax on unhealthy foods?Absent
Tax on unhealthy drinks?Absent
Are there fiscal policies on healthy products?Absent
Subsidy on fruits?Absent
Subsidy on vegetables?Absent
Subsidy on other healthy products?Absent
Mandatory limit or ban of trans fat (all settings)?Absent
Mandatory limit of trans fats in place (all settings)? Absent
Ban on trans-fats or phos in place (all settings)? Absent
Are there any mandatory policies/marketing restrictions on the promotion of unhealthy food/drinks to children?Absent
Mandatory restriction on broadcast media?Absent
Mandatory restriction on non-broadcast media?Absent
Voluntary policies/marketing restrictions on the promotion of unhealthy food/drinks to children?Absent
Are there mandatory standards for food in schools?Absent
Are there any mandatory nutrient limits in any manufactured food products?Absent
Nutrition standards for public sector procurement?Absent

Political will and support

National obesity strategy or nutrition and physical activity national strategy?Present
National obesity strategy?Present
National childhood obesity strategy?Absent
Comprehensive nutrition strategy?Present
Comprehensive physical activity strategy?Present
Evidence-based dietary guidelines and/or RDAs?Absent
National target(s) on reducing obesity?Present
Promotion of breastfeeding?Present

Monitoring and surveillance

Monitoring of the prevalence and incidence for the main obesity-related NCDs and risk factors?Absent
Within 5 years?Absent

Governance and resource

Multi-sectoral national co-ordination mechanism for obesity or nutrition (including obesity)?Absent

Key

Present
Present (voluntary)
Incoming
Absent
Unknown

Last updated September 13, 2022

See more policies here

Download contextual factors as a PDF Contextual factors definitions

Feedback

Are you finding the information on these pages useful?
Yes
No
N/A

Thank you for feeding back to World Obesity.

If you have any further feedback or suggestions please email us at obesity@worldobesity.org.

Close
Loading